Vulnerability markers in the schizophrenia spectrum: Implications for phenomenology, genetics, and the identification of the schizophrenia prodrome

Psychiatric Clinics of North America

Volumn 25, Issue 4, 2002, Pages 837-853

  Cadenhead, Kristin S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROLEPTIC AGENT;

AGE DISTRIBUTION; ANAMNESIS; COGNITION; COMORBIDITY; DISEASE PREDISPOSITION; EVENT RELATED POTENTIAL; FAMILY HISTORY; GENETIC ANALYSIS; GENOTYPE; HIGH RISK POPULATION; HUMAN; NERVE CELL DIFFERENTIATION; PATIENT REFERRAL; PHENOMENOLOGY; PHENOTYPE; PREDICTION; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK FACTOR; SCHIZOPHRENIA; SCHIZOTYPAL PERSONALITY DISORDER; STARTLE REFLEX;

PERSONALITY; RISK FACTORS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SCHIZOTYPAL PERSONALITY DISORDER; SYNDROME;

EID: 0036889750     PISSN: 0193953X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0193-953X(02)00021-7     Document Type: Review

References (118)

1. Bleuler E. Dementia Praecox; or, the Group of Schizophrenias. Monograph series on schizophrenia; no. 1. New York: International Universities Press; 1964.
2. Kendler KS, Gruenberg AM, Kinney DK. Independent diagnoses of adoptees and relatives as defined by DSM-III in the Provincial and national samples of the Danish adoption study of schizophrenia. Arch Gen Psychiatry 1994;51:456-68.
3. Kety S, Wender P, Jacobsen L, Ingraham L, Jansson L, Faber B, et al. Mental illness in the biological and adoptive relatives of schizophrenic adoptees: Replication of the Copenhagen study in the rest of Denmark. Arch Gen Psychiatry 1994;51:442-55.
4. Kraepelin E. Dementia Praecox: The Clinical Roots of the Schizophrenia Concept. Translations of Seminal European Contributions on Schizophrenia. Cambridge (UK): Cambridge University Press; 1987. p. 13-24.
5. Rosanoff A. A study of heredity in insanity in light of the mendelian theory. American Journal of Insanity 1911;1:211-34.
6. Deutsch H. Some forms of emotional disturbance and their relationship to schizophrenia. Psychoanal Q 1944;11:301-21.
7. Hoch PH, Cattell JP. The diagnosis of pseudoneurotic schizophrenia. Psychiatr Q 1959;33:17-43.
8. Knight RP. Borderline states. Bull Menninger Clin 1953;17:1-2.
9. Kretschmer E. Die rolle der vererbung und der konstitution in der aetiologie der seelischen stoerungen. Nederlandsch Tijdschrift Voor Psychologie 1938;5:388-400.
10. Rado S. Dynamics and classification of disordered behavior. Am J Psychiatry 1953;110:406-26.
11. Meehl PE. Schizotaxia, schizotypy, schizophrenia. Am Psychol 1962;17:827-38.
12. Kety SS, Rosenthal D, Wender PH, Schulsinger F. Mental illness in the biological and adoptive families of adopted schizophrenics. Am J Psychiatry 1971;128:302-6.
13. Kendler KS, Walsh D. Schizotypal personality disorder in parents and the risk for schizophrenia in siblings. Schizophr Bull 1995;21:47-52.
14. Grinker R, Werble B, Drue R. The Borderline Syndrome. New York: Basic Books, Inc; 1968.
15. Kernberg O. Borderline personality organization. J Am Psychoanal Assoc 1967;15:641-85.
16. Spitzer RL, Endicott J, Gibbon M. Crossing the border into borderline personality and borderline schizophrenia: The development of criteria. Arch Gen Psychiatry 1979;36:17-24.
17. Gunderson JG, Singer MT. Defining borderline patients: An overview. Am J Psychiatry 1975;132:1-10.
18. George A, Soloff PM. Schizotypal symptoms in patients with borderline personality disorders. Am J Psychiatry 1986;143:212-5.
19. Pope HG, Jonas JM, Cohen BM, Lipinski JF. Failure to find evidence of schizophrenia in first-degree relatives of schizophrenic probands. Am J Psychiatry 1982;139:826-8.
20. Keefe RS, Silverman JM, Siever LJ, Cornblatt BA. Refining phenotype characterization in genetic linkage studies of schizophrenia. Soc Biol 1991;38:197-218.
21. Siever LJ, Gunderson JG. The search for a schizotypal personality: Historical origins and current status. Compr Psychiatry 1983;24:199-212.
22. Siever LJ, Kalus OF, Keefe RS. The boundaries of schizophrenia. Psychiatr Clin North Am 1993;16:217-44.
23. Kendler KS, Ochs AL, Gorman AM, Hewitt JK. The structure of schizotypy: A pilot multitrait twin study. Psychiatry Res 1991;36:19-36.
24. Battaglia M, Cavallini MC, Macciardi F, Bellodi L. The structure of DSM-III-R schizotypal personality disorder diagnosed by direct interviews. Schizophr Bull 1997;23:83-92.
25. Battaglia M, Fossati A, Torgersen S, Bertella S, Bajo S, Maffei C, et al. A psychometric-genetic study of schizotypal disorder. Schizophr Res 1999;37:53-64.
26. Bergman AJ, Silverman JM, Harvey PD, Smith CJ, Siever LJ. Schizotypal symptoms in the relatives of schizophrenia patients: An empirical analysis of the factor structure. Schizophr Bull 2000;26:577-86.
27. Reynolds CA, Raine A, Mellingen K, Venables PH, Mednick SA. Three-factor model of schizotypal personality: Invariance across culture, gender, religious affiliation, family adversity, and psychopathology. Schizophr Bull 2000;26:603-18.
28. Venables PH, Rector NA. The content and structure of schizotypy: A study using confirmatory factor analysis. Schizophr Bull 2000;26:587-602.
29. Baron M, Gruen R, Asnis L, Kane JM. Familial relatedness of schizophrenia and schizotypal states. Am J Psychiatry 1983;140:1437-42.
30. Onstad S, Skre I, Edvardsen J, Torgersen S, Kringlen E. Mental disorders in first-degree relatives of schizophrenics. Acta Psychiatr Scand 1991;83:463-7.
31. Kendler KS, Masterson CC, Ungaro R, Davis KL. A family history study of schizophrenia-related personality disorders. Am J Psychiatry 1984;141:424-7.
32. Baron M, Gruen R, Rainer JD, Kane J, Asnis L, Lord S. A family study of schizophrenic and normal control probands: Implications for the spectrum concept of schizophrenia. Am J Psychiatry 1985;142:447-55.
33. Battaglia M, Bernardeschi L, Franchini L, Bellodi L. A family study of schizotypal disorder. Schizophr Bull 1995;21:33-45.
34. Kety SS. Mental illness in the biological and adoptive relatives of schizophrenic adoptees: Findings relevant to genetic and environmental factors in etiology. Am J Psychiatry 1983;140:720-7.
35. Maier W, Lichtermann D, Minges J, Heun R. Personality disorders among the relatives of schizophrenia patients. Schizophr Bull 1994;20:481-93.
36. Thaker G, Adami H, Moran M, Lahti A, Cassady S. Psychiatric illnesses in families of subjects with schizophrenia-spectrum personality disorders: High morbidity risks for unspecified functional psychoses and schizophrenia. Am J Psychiatry 1993;150:66-71.
37. Varma SL, Zain AM, Singh S. Psychiatric morbidity in the first-degree relatives of schizophrenic patients. Am J Med Genet 1997;74:7-11.
38. Fenton W, McGlashan T. Risk of schizophrenia in character disordered patients. Am J Psychiatry 1989;146:1280-4.
39. Frangos E, Athanassenas G, Tsitourides S, Katsanou N, Alexandrakou P. Prevalence of DSM III schizophrenia among the first-degree relatives of schizophrenic probands. Acta Psychiatr Scand 1985;72:382-6.
40. Gershon ES, DeLisi LE, Hamovit J, Nurnberger JI Jr., Maxwell ME, Schreiber J, et al. A controlled family study of chronic psychoses: Schizophrenia and schizoaffective disorder. Arch Gen Psychiatry 1988;45:328-36.
41. Lowing PA, Mirsky AF, Pereira R. The inheritance of schizophrenia spectrum disorders: A reanalysis of the Danish adoptee study data. Am J Psychiatry 1983;140:1167-71.
42. Battaglia M, Bellodi L. Familial risks and reproductive fitness in schizophrenia. Schizophr Bull 1996;22:191-5.
43. Battaglia M, Gasperini M, Sciuto G, Scherillo P, Diaferia G, Bellodi L. Psychiatric disorders in the families of schizotypal subjects. Schizophr Bull 1991;17:659-68.
44. Berenbaum H, McGrew J. Familial resemblance of schizotypic traits. Psychol Med 1993;23:327-33.
45. Ingraham LJ. Family-genetic research and schizotypal personality research. In: Raine A, Lencz T, Mednick SA, editors. Schizotypal Personality. New York: Cambridge University Press; 1995. p. 19-42.
46. Siever LJ, Silverman JM, Horvath TB, Klar H, Coccaro E, Keefe RS, et al. Increased morbid risk for schizophrenia-related disorders in relatives of schizotypal personality disordered patients. Arch Gen Psychiatry 1990;47:634-40.
47. Silverman JM, Siever LJ, Horvath TB, Coccaro EF, Klar H, Davidson M, et al. Schizophrenia-related and affective personality disorder traits in relatives of probands with schizophrenia and personality disorders. Am J Psychiatry 1993;150:435-42.
48. Freedman R, Coon H, Myles-Worsley M, Orr-Urtreger A, Olincy A, Davis A, et al. Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus. Proc Natl Acad Sci USA 1997;94:587-92.
49. Hyman SE. The NIMH perspective: Next steps in schizophrenia research. Biol Psychiatry 2000;47:1-7.
50. Siever LJ. Brain structure/function and the dopamine system in schizotypal personality disorder. In: Raine A, Lencz T, Mednick SA, editors. Schizotypal Personality. New York: Cambridge University Press; 1995. p. 272-86.
51. Venables P. Input dysfunction in schizophrenia. In: Maher B, editor. Progress in Experimental Personality Research. New York: Academic Press; 1964. p. 1-41.
52. Braff DL. Psychophysiological and information processing approaches to schizophrenia. In: Charney DS, Nestler E, Bunney BS, editors. Neurobiological Foundation of Mental Illness. New York: Oxford University Press; 1999. p. 258-71.
53. Tsuang MT. Recent advances in genetic research on schizophrenia. J Biomed Sci 1998;5:28-30.
54. Braff DL. Information processing and attention dysfunctions in schizophrenia. Schizophr Bull 1993;19:233-59.
55. Braff DL, Grillon C, Geyer MA. Gating and habituation of the startle reflex in schizophrenic patients. Arch Gen Psychiatry 1992;49:206-15.
56. Cadenhead K, Geyer M, Braff D. Impaired startle prepulse inhibition and habituation in schizotypal personality disordered patients. Am J Psychiatry 1993;150:1862-7.
57. Cadenhead KS, Swerdlow NR, Shafer K, Diaz M, Braff DL. Modulation of the startle response and startle laterality in relatives of schizophrenia patients and schizotypal personality disordered subjects: Evidence of inhibitory deficits. Am J Psychiatry 2000;157:1660-8.
58. Cadenhead K, Light G, Geyer M, Braff D. P50 event-related-potential sensory gating deficits in schizotypal personality disordered subjects. Am J Psychiatry 2000;157:55-9.
59. Clementz B, Geyer M, Braff D. Poor P50 suppression among schizophrenia patients and their first-degree biological relatives. Am J Psychiatry 1998;155:1691-4.
60. Waldo MC, Carey G, Myles-Worsley M, Cawthra E, Adler LE, Nagamoto HT, et al. Codistribution of a sensory gating deficit and schizophrenia in multi-affected families. Psychiatry Res 1991;39:257-68.
61. Brenner CA, McDowell JE, Cadenhead KS, Clementz BA. Saccadic inhibition among schizotypal personality disorder and schizophrenia subjects. Psychophysiology 2001;38:399-403.
62. Katsanis J, Kortenkamp S, Iacono WG, Grove WM. Antisaccade performance in patients with schizophrenia and affective disorder. J Abnorm Psychol 1997;106:468-72.
63. Ross RG, Harris JG, Olincy A, Radant A, Adler LE, Freedman R. Familial transmission of two independent saccadic abnormalities in schizophrenia. Schizophr Res 1998;30:59-70.
64. Kumari V, Soni W, Mathew VM, Sharma T. Prepulse inhibition of the startle response in men with schizophrenia: Effects of age of onset of illness, symptoms, and medication. Arch Gen Psychiatry 2000;57:609-14.
65. Cadenhead KS, Carasso B, Swerdlow NR, Geyer MA, Braff DL. Prepulse inhibition and habituation of the startle response are stable neurobiological measures in a normal male population. Biol Psychiatry 1999;45:360-4
66. Grillon C, Ameli R, Charney DS, Krystal J, Braff D. Startle gating deficits occur across prepulse intensities in schizophrenic patients. Biol Psychiatry 1992;32:939-43.
67. Kumari V, Soni W, Sharma T. Normalization of information processing deficits in schizophrenia with clozapine. Am J Psychiatry 1999;156:1046-51.
68. Nuechterlein KH, Dawson ME. Information processing and attentional functioning in the developmental course of schizophrenic disorders. Schizophr Bull 1984;10:160-203.
69. Weike AI, Bauer U, Hamm AO. Effective neuroleptic medication removes prepulse inhibition deficits in schizophrenia patients. Biol Psychiatry 2000;47:61-70.
70. Cadenhead K, Braff DL. Enophenotyping schizotypy: A prelude to genetic studies within the schizophrenia spectrum. Schizophr Res 2002;54:47-57.
71. Swerdlow NR, Braff DL, Taaid N, Geyer MA. Assessing the validity of an animal model of deficient sensorimotor gating in schizophrenic patients. Arch Gen Psychiatry 1994;51:139-54.
72. Carlson SR, Katsanis J, Iacono WG, McGue M. Emotional modulation of the startle reflex in twins: Preliminary findings. Biol Psychol 1997;46:235-46.
73. Bullock AE, Slobe BS, Vázquez V, Collins AC. Inbred mouse strains differ in the regulation of startle and prepulse inhibition of the startle response. Behav Neurosci 1997;111:1353-60.
74. Paylor R, Crawley JN. Inbred strain differences in prepulse inhibition of the mouse startle response. Psychopharmacology (Berl) 1997;132:169-80.
75. Joober R, Zarate JM, Rouleau GA, Skamene E, Boksa P. Quantitative trait loci modulating the acoustic startle response and prepulse inhibition of acoustic startle. Society for Neuroscience Proceedings 2001 (abstract).
76. Adler LE, Pachtman E, Franks RD, Pecevich M, Waldo MC, Freedman R. Neurophysiological evidence for a defect in neuronal mechanisms involved in sensory gating in schizophrenia. Biol Psychiatry 1982;17:639-54.
77. Freedman R, Adler LE, Waldo M. Gating of the auditory evoked potential in children and adults. Psychophysiology 1987;24:223-7.
78. Myles-Worsley M, Coon H, Byerley W, Waldo M. Developmental and genetic influences on the P50 sensory gating phenotype. Biol Psychiatry 1996;39:289-95.
79. Boutros NN, Overall J, Zouridakis G. Test-retest reliability of the P50 mid-latency auditory evoked response. Psychiatry Res 1991;39:181-92.
80. Waldo MC, Graze K, de Graff Bender S, Adler LE, Freedman R. Premenstrual mood changes and gating of the auditory evoked potential. Psychoneuroendocrinology 1987;12:35-40.
81. Clementz BA, Geyer MA, Braff DL. P50 suppression among schizophrenia and normal comparison subjects: A methodological analysis. Biol Psychiatry 1997;41:1035-44.
82. Freedman R, Adler LE, Waldo MC, Pachtman E, Franks RD. Neurophysiological evidence for a defect in inhibitory pathways in schizophrenia: Comparison of medicated and drug-free patients. Biol Psychiatry 1983;18:537-51.
83. Judd LL, McAdams L, Budnick B, Braff DL. Sensory gating deficits in schizophrenia: New results. Am J Psychiatry 1992;149:488-93.
84. Siegel C, Waldo M, Mizner G, Adler LE, Freedman R. Deficits in sensory gating in schizophrenic patients and their relatives: Evidence obtained with auditory evoked responses. Arch Gen Psychiatry 1984;41:607-12.
85. Young D, Waldo M, Rutledge J, Freedman R. Heritability of inhibitory gating of the P50 auditory-evoked potential in monozygotic and dizygotic twins. Neuropsychobiology 1996;33:113-7.
86. Light GA, Geyer MA, Clementz BA, Cadenhead KS, Braff DL. Normal P50 suppression in schizophrenia patients treated with atypical antipsychotic medications. Am J Psychiatry 2000;157:767-71.
87. Nagamoto HT, Adler LE, Hea RA, Griffith JM, McRae KA, Freedman R. Gating of auditory P50 in schizophrenics: Unique effects of clozapine. Biol Psychiatry 1996;40:181-8.
88. Nagamoto HT, Adler LE, McRae KA, Huettl P, Cawthra E, Gerhardt G, et al. Auditory P50 in schizophrenics on clozapine: Improved gating parallels clinical improvement and changes in plasma 3-methoxy-4-hydroxyphenylglycol. Neuropsychobiology 1999;39:10-7.
89. Yee CM, Nuechterlein KH, Morris SE, White PM. P50 suppression in recent-onset schizophrenia: Clinical correlates and risperidone effects. J Abnorm Psychol 1998;107:691-8.
90. Fukushima J, Morita N, Fukushima K, Chiba T, Tanaka S, Yamashita I. Voluntary control of saccadic eye movements in patients with schizophrenic and affective disorders. J Psychiatr Res 1990;24:9-24.
91. McDowell JE, Myles-Worsley M, Coon H, Byerley W, Clementz BA. Measuring liability for schizophrenia using optimized antisaccade stimulus parameters. Psychophysiology 1999;36:138-41.
92. Cadenhead K, Light G, Geyer M, McDowell J, Braff D. Neurobiological measures in schizotypal personality disorder: Beginning to define a phenotype? Am J Psychiatry 2002;159:869-71.
93. Myles-Worsley M, Coon H, McDowell J, Brenner C, Hoff M, Lind B, et al. Linkage of a composite inhibitory phenotype to a chromosome 22q locus in eight Utah families. Am J Med Genet 1999;88:544-50.
94. McGlashan TH. Early detection and intervention of schizophrenia: Rationale and research. Br J Psychiatry 1998;172(Suppl):3-6.
95. Sullivan HS. The onset of schizophrenia. Am J Psychiatry 1994;151:135-9.
96. Lieberman JA, Alvir JM, Woerner M, Degreef G, Bilder RM, Ashtari M, et al. Prospective study of psychobiology in first-episode schizophrenia at Hillside Hospital. Schizophr Bull 1992;18:351-71.
97. Vaglum P. Earlier detection and intervention in schizophrenia: Unsolved questions. Schizophr Bull 1996;22:347-51.
98. Tsuang MT, Stone WS, Seidman LJ, Faraone SV, Zimmet S, Wojcik J, et al. Treatment of nonpsychotic relatives of patients with schizophrenia: Four case studies. Biol Psychiatry 1999;45:1412-8.
99. Beiser M, Erickson D, Fleming JA, Iacono WG. Establishing the onset of psychotic illness. Am J Psychiatry 1993;150:1349-54.
100. Docherty JP, Van Kammen DP, Siris SG, Marder SR. Stages of onset of schizophrenic psychosis. Am J Psychiatry 1978;135:420-6.
101. Hafner H. Onset and course of the first schizophrenic episode. Kao Hsiung I Hsueh Ko Hsueh Tsa Chih 1998;14:413-31.
102. Yung AR, Phillips LJ, McGorry PD, McFarlane CA, Francey S, Harrigan S, et al. Prediction of psychosis: A step towards indicated prevention of schizophrenia. Br J Psychiatry 1998;172(Suppl):14-20.
103. Bowers MB Jr, Freedman DX. "Psychedelic" experiences in acute psychoses. Arch Gen Psychiatry 1966;15:240-8.
104. Chapman J. The early symptoms of schizophrenia. Br J Psychiatry 1966;112:225-51.
105. Klosterkotter J, Hellmich M, Steinmeyer EM, Schultze-Lutter F. Diagnosing schizophrenia in the initial prodromal phase. Arch Gen Psychiatry 2001;58:158-64.
106. Davidson M, Reichenberg A, Rabinowitz J, Weiser M, Kaplan Z, Mordehai M. Behavioral and intellectual markers for schizophrenia in apparently healthy male adolescents. Am J Psychiatry 1999;156:1328-35.
107. Weiser M, Reichenberg A, Rabinowitz J, Kaplan Z, Mark M, Bodner E, et al. Association between nonpsychotic psychiatric diagnoses in adolescent males and subsequent onset of schizophrenia. Arch Gen Psychiatry 2001;58:959-64.
108. Cornblatt B, Obuchowski RS, Goldman RS, Bergman A, Smith C, Baruch-Feldman C, et al. This Hillside RAPP Clinic: Intervention during the schizophrenia prodrome. Biol Psychiatry 1998;43:84S.
109. Falloon IR, Coverdale JH, Laidlaw TM, Merry S, Kydd RR, Morosini P. Early intervention for schizophrenic disorders: Implementing optimal treatment strategies in routine clinical services. OTP Collaborative Group. Br J Psychiatry 1998;172(Suppl):33-8.
110. McGorry P. Preventive strategies in early psychosis: Verging on reality. [editorial]. Br J Psychiatry 1998;172(Suppl):1-2.
111. McGlashan TH. Early detection and intervention in schizophrenia: Editor's introduction. Schizophr Bull 1996;22:197-9.
112. McGorry PD, Edwards J, Mihalopoulos C, Harrigan SM, Jackson HJ. EPPIC: an evolving system of early detection and optimal management. Schizophr Bull 1996;22:305-26.
113. Cornblatt B, Obuchowski M. Update of high-risk research: 1987-1997. Int Rev Psychiatry 1997;9:437-47.
114. Larsen TK, McGlashan TH, Moe LC. First-episode schizophrenia: I. Early course parameters. Schizophr Bull 1996;22:241-56.
115. Falloon IR. Early intervention for first episodes of schizophrenia: A preliminary exploration. Psychiatry 1992;55:4-15.
116. McGorry P, Phillips L, Yung A, Francey S, Velakoulis D, Brewer W, et al. The identification of predictors of psychosis in a high risk group. Schizophr Res 1999;36:49-50.
117. Larsen T, Joa I. Identifying person's prodromal to first episode schizophrenia: The TOPP-Orihect. Curr Opin Psychiatry 1999;12:207.
118. Larsen TK, Friis S, Haahr U, Joa I, Johannessen JO, Melle I, et al. Early detection and intervention in first-episode schizophrenia: A critical review. Acta Psychiatr Scand 2001;103:323-34.